Vineet Agrawal, MD
Payments from drug & device makers
Across 36 payments — averaging $105.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Cook Incorporated$250
- Olympus America Inc.$208
- Coloplast$169
- Procept Biorobotics Corporation$151
- Cook Medical LLC$88
- plus $384 from 13 others
What the payments were for
- Speaking & faculty fees$2507%
- Travel & lodging$2,08355%
- Food & beverage$1,42838%
- Education$351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $2,546 |
| Cook Incorporated | 1 | $250 |
| Olympus America Inc. | 2 | $208 |
| Coloplast | 4 | $169 |
| Procept Biorobotics Corporation | 2 | $151 |
| Cook Medical LLC | 1 | $88 |
| Calyxo, Inc. | 2 | $86 |
| KARL Storz Endoscopy-america | 1 | $67 |
| Laborie Medical Technologies Corp. | 1 | $41 |
| AstraZeneca | 1 | $35 |
| Antares Pharma, Inc. | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| AbbVie | 1 | $16 |
| Ambu Inc. | 1 | $15 |
| Photocure Inc | 1 | $15 |
| Rochester Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lumenis Pulse 120H$2,099
- iTIND System$161
- AQUABEAM SYSTEM$119
- Moses 550 DFL$104
- Porges Coloplast$103
How this compares
$3,795 in reported general payments places this provider in the 60th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 127 | $84,714 |
| Tamsulosin Hcl | 366 | $5,271 |
| Oxybutynin Chloride ErOxybutynin Chloride | 161 | $3,153 |
| Finasteride | 127 | $1,360 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,119 |
| NitrofurantoinNitrofurantoin Macrocrystal | 33 | $1,099 |
| Testosterone Cypionate | 17 | $390 |
| Cephalexin | 12 | $388 |
| Ciprofloxacin Hcl | 106 | $360 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 46 | $331 |
| Oxybutynin Chloride | 20 | $225 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $97 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $46 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $32 |
Paid to pharmacies, not to this prescriber.
Other urology in Sayre
- Laurence BelkoffBala Cynwyd$18.7M
- Paul SieberLancaster$12.6M
- Costas LallasPhiladelphia$3.6M
- John AndersonBethlehem$2.1M
- Jodi MaranchiePittsburgh$1.2M
- Kenneth LessansLancaster$943K
- Stanley MalkowiczPhiladelphia$882K
- Demetrius BagleyPhiladelphia$739K
- Gregory TasianPhiladelphia$645K
- Eugene PietzakPhiladelphia$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.